| 摘要 |
Pharmaceutical compositions containing highly-concentrated lyophilized lactic bacteria in combination with pharmacologically acceptable excipients and optionally suitable physiologically compatible drugs, are adapted for restoring the intestinal mucous membrane mass and modulating the epithelial cell kinetics and the enzyme potential of the intestine when they have been altered as a result of stress conditions, and in, addition in case of gastroenteritis, colitis, constipation, diarrhoea, for recolonizing the intestine after food disorders, surgical interventions, chemotherapy or contagious deseases, hepatopathies resulting from toxic, metabolic or infectious causes, as adjuvants for controlling hyperammonemia and endotoxinemia while liver insufficiency is in progress, in case of lack of humoral immunity and of mucosal and systemic cell-mediated immunity associated with secondary immunological deficiency diseases, for hyperlipoproteinemia and hypercholesteremia, and as adjuvants in diabetes therapy. |
